First human test of new drug VRG50635 completed
NCT ID NCT06286475
Summary
This was the first study in humans for the experimental drug VRG50635. Its main goals were to check if the drug is safe and to see how the body absorbs and processes it. The study involved 22 healthy adult volunteers who received single or multiple doses of the drug. This type of early study is a standard first step before testing a drug in people with a specific illness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lincoln Celerion Inc.,
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.